CHP Perspectives
How we think about evidence, adoption and capital.
These are our own viewpoints, written from CHP's investment thesis. They are not research findings, advice or announcements of completed activity.
All perspectives
- CHP Perspective
Why evidence should guide HealthTech capital
An investment thesis becomes stronger when technical promise is examined alongside clinical use and commercial reality.
Read - CHP Perspective
Clinical workflow belongs in the investment thesis
Assessing a technology means understanding the people, processes and care settings around it.
Read - CHP Perspective
From global innovation to regional adoption
A regional growth strategy starts with clinical relevance, implementation requirements and a credible route to market.
Read